LIFECORE BIOMEDICAL, INC. \DE\ Net Income Loss

Quick Answer

LIFECORE BIOMEDICAL, INC. \DE\ reported Net Income Loss of -$38.72 million for the year ending 2025.

  • LIFECORE BIOMEDICAL, INC. \DE\ showed a decrease of -422.3% in Net Income Loss from 2024 to 2025.
  • This data is from LIFECORE BIOMEDICAL, INC. \DE\'s annual report (Form 10-K), filed with the SEC on August 7, 2025.
  • XBRL data for this metric is available from 2010 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 15 years of available data (2010 to 2025), LIFECORE BIOMEDICAL, INC. \DE\'s Net Income Loss has declined by 1,071.8%.
  • Historical annual values: Fiscal year 2025: -$38.72 million | Fiscal year 2024: $12.01 million | Fiscal year 2023: -$99.56 million | Fiscal year 2022: -$116.72 million | Fiscal year 2021: -$32.29 million | Fiscal year 2020: -$38.19 million | Fiscal year 2019: $411.0 thousand | Fiscal year 2018: $24.83 million | Fiscal year 2017: $10.59 million | Fiscal year 2016: -$11.64 million | Fiscal year 2015: $13.54 million | Fiscal year 2013: $22.59 million | Fiscal year 2012: $12.70 million | Fiscal year 2011: $3.92 million | Fiscal year 2010: $3.98 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: